technetium tc 99m hydroxymethylene diphosphonate and Neuroleptic Malignant Syndrome

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Neuroleptic Malignant Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukuda, T; Ishii, K; Kanata, J; Kita, Y; Kono, AK; Miyamoto, N; Sasaki, H	1

Other Studies

1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Neuroleptic Malignant Syndrome

Article	Year
Early disappearance of calcification in posterior paraspinal muscles in a patient with rhabdomyolysis associated with neuroleptic malignant syndrome. Radiation medicine, 2006, Volume: 24, Issue:6 Topics: Acute Kidney Injury; Adult; Biomarkers; Bone and Bones; Calcinosis; Humans; Male; Muscle, Skeletal; Neuroleptic Malignant Syndrome; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyolysis; Technetium Tc 99m Medronate; Time Factors; Tomography, X-Ray Computed	2006

Article

Year

Early disappearance of calcification in posterior paraspinal muscles in a patient with rhabdomyolysis associated with neuroleptic malignant syndrome.

Radiation medicine, 2006, Volume: 24, Issue:6

Topics: Acute Kidney Injury; Adult; Biomarkers; Bone and Bones; Calcinosis; Humans; Male; Muscle, Skeletal; Neuroleptic Malignant Syndrome; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyolysis; Technetium Tc 99m Medronate; Time Factors; Tomography, X-Ray Computed

2006